BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 22908926)

  • 41. Metabolic syndrome in the prevention of cardiovascular diseases and diabetes--still a matter of debate?
    Ma X; Zhu S
    Eur J Clin Nutr; 2013 May; 67(5):518-21. PubMed ID: 23403882
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Metabolic Syndrome: clinical and pathophysiological basis for a rational therapeutical approach].
    Martínez R G; Alonso K R; Novik A V
    Rev Med Chil; 2009 May; 137(5):685-94. PubMed ID: 19701560
    [TBL] [Abstract][Full Text] [Related]  

  • 43. SLE and metabolic syndrome.
    Parker B; Bruce I
    Lupus; 2013 Oct; 22(12):1259-66. PubMed ID: 24097998
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The obesity epidemic and its cardiovascular consequences.
    Behn A; Ur E
    Curr Opin Cardiol; 2006 Jul; 21(4):353-60. PubMed ID: 16755205
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Obesity-related hypertension: pathogenesis, cardiovascular risk, and treatment--a position paper of the The Obesity Society and The American Society of Hypertension.
    Landsberg L; Aronne LJ; Beilin LJ; Burke V; Igel LI; Lloyd-Jones D; Sowers J
    Obesity (Silver Spring); 2013 Jan; 21(1):8-24. PubMed ID: 23401272
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of adipokines in cardiovascular disease.
    Mattu HS; Randeva HS
    J Endocrinol; 2013 Jan; 216(1):T17-36. PubMed ID: 23160967
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Overweight and obesity: the pathogenesis of cardiometabolic risk.
    Bray GA; Clearfield MB; Fintel DJ; Nelinson DS
    Clin Cornerstone; 2009; 9(4):30-40; discussion 41-2. PubMed ID: 19789062
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The metabolic syndrome, insulin resistance and cardiovascular disease.
    Ascott-Evans B
    Cardiovasc J S Afr; 2002; 13(4):187-8. PubMed ID: 12389061
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adipose inflammation, insulin resistance, and cardiovascular disease.
    Shah A; Mehta N; Reilly MP
    JPEN J Parenter Enteral Nutr; 2008; 32(6):638-44. PubMed ID: 18974244
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Redox-inflammatory synergy in the metabolic syndrome.
    Bryan S; Baregzay B; Spicer D; Singal PK; Khaper N
    Can J Physiol Pharmacol; 2013 Jan; 91(1):22-30. PubMed ID: 23368637
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Biomarkers for cardiovascular risk in children.
    Canas JA; Sweeten S; Balagopal PB
    Curr Opin Cardiol; 2013 Mar; 28(2):103-14. PubMed ID: 23337894
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Thrombosis in central obesity and metabolic syndrome: mechanisms and epidemiology.
    Morange PE; Alessi MC
    Thromb Haemost; 2013 Oct; 110(4):669-80. PubMed ID: 23765199
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Endothelial Dysfunction in Obesity: Role of Inflammation.
    Virdis A
    High Blood Press Cardiovasc Prev; 2016 Jun; 23(2):83-5. PubMed ID: 27000854
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Modified resveratrol Longevinex improves endothelial function in adults with metabolic syndrome receiving standard treatment.
    Fujitaka K; Otani H; Jo F; Jo H; Nomura E; Iwasaki M; Nishikawa M; Iwasaka T; Das DK
    Nutr Res; 2011 Nov; 31(11):842-7. PubMed ID: 22118755
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Metabolic syndrome].
    Takata H; Fujimoto S
    Nihon Rinsho; 2013 Feb; 71(2):266-9. PubMed ID: 23631204
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The link between abdominal obesity, metabolic syndrome and cardiovascular disease.
    Ritchie SA; Connell JM
    Nutr Metab Cardiovasc Dis; 2007 May; 17(4):319-26. PubMed ID: 17110092
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Endothelial dysfunction, obesity and insulin resistance.
    Prieto D; Contreras C; Sánchez A
    Curr Vasc Pharmacol; 2014 May; 12(3):412-26. PubMed ID: 24846231
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Endothelial dysfunction associated with obesity and the effect of weight loss interventions.
    Kerr SM; Livingstone MB; McCrorie TA; Wallace JM
    Proc Nutr Soc; 2011 Nov; 70(4):418-25. PubMed ID: 21861950
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sex hormone imbalances and adipose tissue dysfunction impacting on metabolic syndrome; a paradigm for the discovery of novel adipokines.
    Zhang H; Sairam MR
    Horm Mol Biol Clin Investig; 2014 Feb; 17(2):89-97. PubMed ID: 25372733
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The metabolic syndrome.
    Harris MF
    Aust Fam Physician; 2013 Aug; 42(8):524-7. PubMed ID: 23971058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.